DEXMEDETOMIDIN Labatec 200 mcg/2ml 5 pce
7680693480018
CH-69348
N05CM18
01.04.1.
1 / 3
google
Details
- Product number
- 6934801
- CPT
- -
- Packaging group
- 5
- Unit
- Ampulle(n)
- Composition
- dexmedetomidinum 200 µg ut dexmedetomidini hydrochloridum, natrii chloridum, aqua ad iniectabile, ad solutionem pro 2 ml corresp. natrium 7.08 mg.
Articles (1)
Dexmedetomidin Labatec 200 μg/2 ml, solution à diluer pour perfusion
Lösung
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.08 MG | Substance | HBESI |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 69348
- Drug name
- Dexmedetomidin Labatec, solution à diluer pour perfusion
- Galenic form
- KOINF
- ATC Code
- N05CM18
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/01/2024
- Authorization expiration date
- 10/01/2029
- IT number
- 01.04.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DEXMEDETOMIDIN Labatec 200 mcg/2ml 5 pce
- Description (DE)
- DEXMEDETOMIDIN Labatec 200 mcg/2ml 5 Stk
- Market launch
- 11/01/2024
- Narcotic (BTM)
- No